Recent studies have reported that SOX3 is upregulated in cancer tissues and may therefore play an oncogenic role in esophageal squamous cell carcinoma, ovarian cancer, and T-cell lymphomas [22–24]. This evidence concerns the gene SOX3 and esophageal squamous cell carcinoma.